Qunol Acquisition Gets Sanofi CHC Off To Flying Start

 
• By Tom Gallen

Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based firm has reached an agreement in principle to resolve the vast majority of Zantac personal injury state court cases in the US.

• Source: Shutterstock

Adding health aging dietary supplements brand Qunol to its portfolio towards the end of last year helped Sanofi Consumer Healthcare’s sales grow almost double-digits in the first quarter of 2024.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography